BioTime

BioTime is building a dominant company in the field of regenerative medicine. Our strategy is to be the leader in the development of pluripotent stem cell-based technologies and to apply those new technologies in the treatment of degenerative diseases that afflict large numbers of people worldwide. We have advanced additional products into human clinical trials over the past year.